{
    "eid": "2-s2.0-84964720733",
    "title": "Antitumor effect of the novel sphingosine kinase 2 inhibitor ABC294640 is enhanced by inhibition of autophagy and by sorafenib in human cholangiocarcinoma cells",
    "cover-date": "2016-04-12",
    "subject-areas": [
        {
            "$": "Oncology",
            "@code": "2730"
        }
    ],
    "keywords": [
        "ABC294640",
        "Autophagy",
        "Cholangiocarcinoma",
        "Sorafenib",
        "Sphingosine kinase 2"
    ],
    "authors": [
        "Xiwei Ding"
    ],
    "citedby-count": 43,
    "ref-count": 42,
    "ref-list": [
        "Epidemiological trends in incidence and mortality of hepatobiliary cancers in Germany",
        "Biliary tract cancers in olmsted county, Minnesota, 1976-2008",
        "Incidence and mortality trends for biliary tract cancers in Austria",
        "Pathogenesis, diagnosis, and management of cholangiocarcinoma",
        "Identification of SPHK1 as a therapeutic target and marker of poor prognosis in cholangiocarcinoma",
        "Overexpression of sphingosine kinase 1 is an oncogenic event in erythroleukemic progression",
        "Sphingosine kinase 11s associated with gastric cancer progression and poor survival of patients",
        "SPHK1 regulates proliferation and survival responses in triplenegative breast cancer",
        "Sphingosine kinase 2 promotes acute lymphoblastic leukemia by enhancing myc expression",
        "Sphingosine 1-phosphate signalling in cancer",
        "Conjugated bile acids promote cholangiocarcinoma cell invasive growth through activation of sphingosine 1-phosphate receptor 2",
        "Targeting NF\u03baB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2",
        "Combined anticancer effects of sphingosine kinase inhibitors and sorafenib",
        "Antitumor activity of sphingosine kinase 2 inhibitor ABC294640 and sorafenib in hepatocellular carcinoma xenografts",
        "Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2",
        "Inhibition of sphingosine kinase 2 downregulates the expression of c-Myc and Mcl-1 and induces apoptosis in multiple myeloma",
        "Targeting sphingosine kinase induces apoptosis and tumor regression for KSHV-associated primary effusion lymphoma",
        "Targeting ovarian cancer and chemoresistance through selective inhibition of sphingosine kinase-2 with ABC294640",
        "Inhibition of sphingosine kinase-2 ablates androgen resistant prostate cancer proliferation and survival",
        "ABC294640, a sphingosine kinase 2 inhibitor, enhances the antitumor effects of TRAIL in non-small cell lung cancer",
        "A novel sphingosine kinase inhibitor induces autophagy in tumor cells",
        "Blocked autophagy using lysosomotropic agents sensitizes resistant prostate tumor cells to the novel Akt inhibitor AZD5363",
        "The role of autophagy in cancer: Therapeutic implications",
        "Autophagy is a survival mechanism of acute myelogenous leukemia precursors during dual mTORC2/mTORC1 targeting",
        "Sorafenib inhibits signal transducer and activator of transcription-3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2",
        "Potent in vitro and in vivo antitumor activity of sorafenib against human Intrahepatic cholangiocarcinoma cells",
        "Interleukin 6 upregulates myeloid cell leukemia-1 expression through a STAT3 pathway in cholangiocarcinoma cells",
        "Sustained IL-6/STAT-3 Signaling in Cholangiocarcinoma Cells Due to SOCS-3 Epigenetic Silencing",
        "Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma",
        "Clinical significance of sphingosine kinase-1 expression in human astrocytomas progression and overall patient survival",
        "Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis",
        "Sphingosine kinase 1 overexpression contributes to cetuximab resistance in human colorectal cancer models",
        "Sphingosine kinase type 2 is a putative BH3-only protein that induces apoptosis",
        "Suppression of colitis-driven colon cancer in mice by a novel small molecule inhibitor of sphingosine kinase",
        "Sphingosine kinase 2 deficient tumor xenografts show impaired growth and fail to polarize macrophages towards an anti-inflammatory phenotype",
        "Sphingosine-1-Phosphate Links Persistent STAT3 Activation, Chronic Intestinal Inflammation, and Development of Colitis-Associated Cancer",
        "Inhibition of active autophagy induces apoptosis and increases chemosensitivity in cholangiocarcinoma",
        "Autophagy in intra-hepatic cholangiocarcinoma",
        null,
        "Regulation of intracellular pH by immortalized human intrahepatic biliary epithelial cell lines",
        "Drug combination studies and their synergy quantification using the chou-talalay method",
        "SULF1 Inhibits Tumor Growth and Potentiates the Effects of Histone Deacetylase Inhibitors in Hepatocellular Carcinoma"
    ],
    "affiliation": [
        {
            "affiliation-city": "Hummelstown",
            "affilname": "Apogee Biotechnology Corporation",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Charleston",
            "affilname": "Medical University of South Carolina",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Rochester",
            "affilname": "Mayo Clinic Cancer Center",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Nanjing",
            "affilname": "Medical School of Nanjing University",
            "affiliation-country": "China"
        }
    ],
    "funding": [
        "National Cancer Institute",
        "National Cancer Institute"
    ]
}